Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
san diego top stories
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
athena countouriotis
bill & melinda gates foundation
biotech ipos
boston
boston blog main
boston top stories
brett zbar
bristol-myers squibb
ceo
clinical trials
co-founder
cormorant asset management
daiichi sankyo
disease
dyne therapeutics
fda
gates foundation
halozyme therapeutics
hbm healthcare investments
hbm partners
health
healthcare
hiv
jean cui
lawyer
lilly asia ventures
massachusetts institute of technology
medication
metacrine
myotonic dystrophy type 1
national top stories
nextech invest
What
drug
3
×
million
raised
3
×
therapeutics
3
×
company
developing
new
acting
aiming
athena
biotech
brings
cancer
ceo
change
chief
consumption
continue
countouriotis
creating
delayed
delivery
disorders
dyne
dyne’s
financing
genetic
gets
ipo
kind
little
long
lyndra
mecha
medical
medicine
medicines
mezzanine
muscle
muscular
Language
unset
Current search:
drug
×
therapeutics
×
raised
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@techcrunch.com
5 years ago
Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
